Skip to search.
 FTSE 100 Up 0.21%

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
0.92 Up 0.28(42.70%) 20:52 - Nasdaq Real Time Price
Prev Close:0.64
Open:0.66
Bid:0.86 x 1200
Ask:0.87 x 100
1y Target Est:4.88
Beta:N/A
Earnings Date:4 Aug - 8 Aug (Est.)
Day's Range:0.62 - 1.00
52wk Range:0.35 - 5.33
Volume:5,165,971
Avg Vol (3m):765,316
Market Cap:19.19m
P/E (ttm):N/A
EPS (ttm):-1.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BIND at this time.

Comparison

Symbol% ChgMkt Cap
BINDUp 42.70%19.19m
PGNXUp 1.01%418.28m
BMYDown 0.69%125.26b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.47
Quarterly EPS Est (Jun-16) :-0.38
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a biotechnology company, develops novel targeted therapeutics primarily for the treatment of cancer in the United States and Russia. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback